medigraphic.com
ISSN 1405-8871 (Print)

2015, Number 1

<< Back Next >>

Aten Fam 2015; 22 (1)

Seroprevalence of Hepatitis C in Family Medicine Units Users in Queretaro, Mexico

Santiago-Torres LE, Camacho-Calderón N, Guerrero-Rodríguez GG

Language: Spanish
References: 35
Page: 2-6
PDF size: 280.20 Kb.


ABSTRACT

Objective: determine the seroprevalence of the Hepatitis C Virus (hcv), in users of three Family Medicine Units (fmu) in Queretaro, Mexico. Methods: cross-sectional, population-based descriptive study, approved by a Committee of Investigation. Non-randomized sample by quota and conglomerates. Study variables: seroprevalence of hcv; history of blood transfusions and seroprevalent hcv family members; use of intravenous drugs, tattoos or piercings; be a worker in health institutions and risky sexual practices. It was obtained, with a prior informed consent, a venous sample of users of the fmu numbers 6, 9 and 16 of the Mexican Institute of Social Security (imss) of Queretaro, Mexico. It was determined Ac anti-hcv by third generation of Enzyme-Linked ImmunoSorbent Assay (elisa) and it was applied a survey for the socio-demographic and epidemiological data. It was used descriptive statistics with support of the spss v15 program. Results: from 7 022 volunteers, the average age was 40.5 ±12. 5 years, there were 62 seropositive to anti-hvc (seroprevalence of 0.882% (ic 95% 0.663-1.101). In the Group of 58-62 years there was higher prevalence (0.270). The most important antecedent was blood transfusion prior to 1995 (0.669). Conclusions: the seroprevalence of hcv in open population is higher than the national average reported in blood donors; blood transfusion was the most frequent antecedent for hepatitis C.


REFERENCES

  1. Zurmendi M, García F. Hepatitis Virales. ArchMed Interna. 2010;33(1):36-47.

  2. Panduro A, Escobedo G, Fierro N, Ruiz B, Zepeda- Carrillo E, Román S. Epidemiología de las hepatitis virales en México. Salud Pública de México. 2011;53(1):37-45.

  3. Aguilera A, Romero S, Regueiroa B. Epidemiología y manifestaciones clínicas de las hepatitis virales. Enferm Infecc Microbiol Clin. 2006;24:264-76.

  4. Benedicto I, Molina-Jiménez F, García-Buey L, Gondar V, López-Cabrera M, Moreno-Otero R, et al. Role of tight junctions in hepatitis C virus infection. Rev Esp Enferm Dig. 2012:104(5);255-63.

  5. Nakatani S, Santoas C, Riediger I, Krieger M, Duarte C, Debur M, et al. Comparative performance evaluation of hepatitis C virus genotyping based on the 5’ untranslated region versus partial sequencing of the NS5B region of Brazilian patients with chronic hepatitis C. Virology Journal. 2011;8:459.

  6. Gottwein J, Acheel T, Jensen T, Lademann J, Prentoe J, Knudsen M, et al. Development and Characterization of Hepatitis C Virus Genotype 1-7 Cell Culture Systems. Hepatology. 2009;49(2):364-77.

  7. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011;17:107-15.

  8. Organización Mundial de la Salud. Hepatitis C. oms[Internet]. 2012;164. Disponible en: http:// www.who.int/mediacentre/factsheets/fs164/es/ index.html

  9. Bruguera M, Forns X. Hepatitis C en España. Medicina clínica. 2006;127:113-7.

  10. Lu J, Zhou Y, Lin X, Jiang Y, Tian R, Zhang Y, et al. General epidemiological parameters of viral hepatitis A, B, C, and E in six regions of China: a cross-sectional study in 2009. Plos One. 2009;4:1-8.

  11. Zaccheaus AJ, Barifebe K, Fiekumo B, Felix E. Prevalence of antibodies to hepatitis C virus in apparently healthy Port Harcourt blood donors and association with blood groups and other risk indicators. Blood Transfus. 2008;6:150-5.

  12. Abou MA, Eltahir YM, Ali AS. Seroprevalence of hepatitis B virus and hepatitis C virus among blood donors in Nyala, South Dar Fur. Sudan Virol J. 2009;6:146.

  13. Armstrong G, Wasley A, Simard E, McQuillan G, Kuhnert W, Alter M. The Prevalence of Hepatitis C Virus Infection in the United States 1999 through 2002. Annals Internal Med. 2006;144:705-15.

  14. Szabo SM, Bibby M, Yong Y, Donato B, Jiménez- Méndez R, Castañeda G, et al. The epidemiologic burden of hepatitis C virus infection in Latin America. Annals of Hepatology. 2012;11(5):623-35.

  15. Dávalos M. Epidemiología de la infección por el virus de la Hepatitis C en el Perú y Latinoamérica. Gastroenterol Perú. 2009;29(4):347-54.

  16. Benítez-Arvizu G, Cortez-Gómez R, Novelo- Garza B, Malagón-Martínez A, Guerra-Márquez A, Alvarado-Maldonado M, et al. Prevalencia del virus de la hepatitis C en el banco de sangre del Centro Médico Nacional La Raza. Rev Med Inst Mex Seguro Soc. 2006;44:227-33.

  17. Valdespino JL, Conde GC, Olaiz FG, Palma O, Kershenobich D, Sepulveda J. Seroprevalencia de la hepatitis C en adultos de México. Salud Pública Mex. 2007;49:395-403.

  18. Sosa-Jurado F, Santos-López G, Guzmán-Flores B, Ruiz-Conde J, Meléndez-Mena D, Vargas- Maldonado M, et al. Hepatitis C virus infection in blood donors from the state of Puebla, Mexico. Virology Journal. 2010;7:18.

  19. Vences AM, González BF. Diagnóstico de la infección por el virus de la hepatitis C en donadores de sangre. Rev Mex Patol Clin. 2005;52:6-12.

  20. Serrano-Machuca J, Villarreal-Ríos E, Galicia- Rodríguez L, Vargas-Daza ER, Martínez-González L, Mejía-Damián AF. Detection of antibodies present in blood donors in Mexico. Rev Panam Salud Pública. 2009;26:355-9.

  21. Dehesa-Violante M, Bosques-Padilla F, Kershenobich- Stalnikowitz D. Prevalence of hepatitis C virus genotypes in Mexican patients. Rev Gastroenterol Mex. 2007;72:344-8.

  22. Harris R, Ramsay M, Hope V, Brant L, Hickman M, Foster G, et al. Hepatitis C prevalence in England remains low and varies by ethnicity. European Journal of Public Health. 2011;1-6.

  23. Cornber M, Razavi H, Alberi A, Bernasconi E, Buti M, Cooper C, et al. A systematic review of hepatitis C virus epidemiology in Europe, Canadá and Israel. Liver International. 2011;31(Suppl 2):30-60.

  24. Sievert W, Altraif I, Razavi H, Ayman A, Ahmed E, AlOmair A, et al. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egyp. Liver International. 2011;31(Suppl 2):61-80.

  25. Valdés J, González O, Rodríguez P, Cardellá L. Hepatitis C II. Principales vías de transmisión e influencia de la edad y el sexo en la infección por el virus de la hepatitis C en 160 pacientes seropositivos. Invest Biomed. 2004;23:209-14.

  26. Secretaría de Salud. Norma Oficial Mexicana. nom-003-ssa2-1993, Para la disposición de sangre humana y sus componentes con fines terapéuticos. Diario Oficial de la Federación; 18: 61-92.

  27. Jaramillo MC, García MV, Restrepo JC. Serología en hepatitis virales. Latreia. 2011;24:76-86

  28. Colquillo B, Sanchez R, Terceros P. Nuevas estrategias para el diagnóstico y seguimiento de la Hepatitis C. biofarbo. 2009;17:15-22.

  29. Jafari S, Copes R, Baharlou S, Etminan M, Buxton J. Tattooing and the risk of transmission of hepatitis C. Internacional Journal of Infectious Diseases. 2010;14:928-40.

  30. Lopes C, Teles S, Espírito-Santo M, Lampe E, Rodrigues F, Motta-Castro A, et al. Prevalencia de factores de riesgo y genotipos de la hepatitis C entre usuarios de drogas. Rev Saúde Pública. 2009;43(1):43-50.

  31. Waure C, Cefalo C, Chiaradia G, Sferrrazza A, Miele L, Gasbarrini G, et al. Intrafamilialtransmission of hepatitis C virus in Italy. J Epidemiol Community Health. 2009;64:843-8.

  32. Plancoulaine S, Mohamed M, Arafa N, Bakr I, Rekacewicz C, Trégouët D, et al. Dissection of familial correlations in hepatitis C virus (hcv) seroprevalence suggests intrafamilial viral transmission and genetic predisposition to infection. Hepatology. 2008;57:1268-74.

  33. Warley E, Desse J, Szyld E, Silva F, Cetani S, Pereyra N, et al. Exposición Ocupacional al virus de la hepatitis C. Medicina Buenos Aires. 2006;66:97-100.

  34. Colichón A, Figueroa R, Moreno A, Zumaetea E, Ferrandiz J, Busalleu A, et al. Prevalencia serológica de anticuerpos al virus de la hepatitis C en personal de salud en el Perú. Rev Gastroenterol. 2004;24:13-20.

  35. Ramos S, Pino E, Galván K, Sernaqué A, Orozco N. Seroprevalencia de Hepatitis C en el personal asistencial del hospital regional de Ayacucho y la microred de salud Huamanga. Rev Peru Med Exp Salud Pública. 2006;23:132-6.




2020     |     www.medigraphic.com